IDEAS home Printed from https://ideas.repec.org/a/eee/hepoli/v123y2019i3p260-266.html
   My bibliography  Save this article

Evidence-informed vaccine decision making: The introduction of Human Papilloma Virus (HPV) vaccination in the Netherlands

Author

Listed:
  • van der Putten, Ingeborg M.
  • Paulus, Aggie T.G.
  • Hiligsmann, Mickael
  • Hutubessy, Raymond C.W.
  • Evers, Silvia M.A.A.

Abstract

Little is known about the role of (economic) information or evidence in the different stages of the decision-making process on vaccine introduction. By conducting a document analysis on the public decision-making process of introducing human Papilloma virus (HPV) vaccine into the national vaccination program (NVP) in the Netherlands, we aim to gain insight into which information plays a role during the introduction of a vaccination programme.

Suggested Citation

  • van der Putten, Ingeborg M. & Paulus, Aggie T.G. & Hiligsmann, Mickael & Hutubessy, Raymond C.W. & Evers, Silvia M.A.A., 2019. "Evidence-informed vaccine decision making: The introduction of Human Papilloma Virus (HPV) vaccination in the Netherlands," Health Policy, Elsevier, vol. 123(3), pages 260-266.
    • Handle: RePEc:eee:hepoli:v:123:y:2019:i:3:p:260-266
    DOI: 10.1016/j.healthpol.2018.09.001
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0168851018304536
    Download Restriction: Full text for ScienceDirect subscribers only
    File URL: https://libkey.io/10.1016/j.healthpol.2018.09.001?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Maria-Laura Silva & John Paget & Anne Mosnier & Valérie Buthion & Jean Marie Cohen & Lionel Perrier & Hans-Martin Späth, 2016. "Development of Seasonal Influenza Vaccination Recommendations: Relevance and Influence of the Evidence on the Decision-Making Process in France and the Netherlands," Post-Print halshs-01366179, HAL.
    2. Silva, Maria Laura & Perrier, Lionel & Paget, John W. & Mosnier, Anne & Buthion, Valérie & Cohen, Jean Marie & Späth, Hans Martin, 2016. "Influenza vaccination policy-making processes in France and The Netherlands: Framework and determinants," Health Policy, Elsevier, vol. 120(3), pages 293-305.
    3. Haas, Marion & Ashton, Toni & Blum, Kerstin & Christiansen, Terkel & Conis, Elena & Crivelli, Luca & Lim, Meng Kin & Lisac, Melanie & MacAdam, Margaret & Schlette, Sophia, 2009. "Drugs, sex, money and power: An HPV vaccine case study," Health Policy, Elsevier, vol. 92(2-3), pages 288-295, October.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Mario García Molina & Liliana Alejandra Chicaíza-Becerra, 2015. "Riesgo, incertidumbre y política pública en vacunas," Revista Cuadernos de Economia, Universidad Nacional de Colombia, FCE, CID, March.
    2. Mezza, Maurizia & Blume, Stuart, 2021. "Turning suffering into side effects: Responses to HPV vaccination in Colombia," Social Science & Medicine, Elsevier, vol. 282(C).
    3. Franco-Trigo, L. & Fernandez-Llimos, F. & Martínez-Martínez, F. & Benrimoj, S.I. & Sabater-Hernández, D., 2020. "Stakeholder analysis in health innovation planning processes: A systematic scoping review," Health Policy, Elsevier, vol. 124(10), pages 1083-1099.
    4. Blume, Stuart & Tump, Janneke, 2010. "Evidence and policymaking: The introduction of MMR vaccine in the Netherlands," Social Science & Medicine, Elsevier, vol. 71(6), pages 1049-1055, September.
    5. Fischer, Katharina E. & Leidl, Reiner & Rogowski, Wolf H., 2011. "A structured tool to analyse coverage decisions: Development and feasibility test in the field of cancer screening and prevention," Health Policy, Elsevier, vol. 101(3), pages 290-299, August.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:123:y:2019:i:3:p:260-266. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.